Article Details

Madrigal Pharmaceuticals has been the subject of unusually high options trading (NASDAQ:MDGL)

Retrieved on: 2022-12-18 03:58:23

Tags for this article:

Click the tags to see associated articles and topics

Madrigal Pharmaceuticals has been the subject of unusually high options trading (NASDAQ:MDGL). View article details on hiswai:

Excerpt

On Thursday, extremely robust options trading activity was focused on Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), which served as the target of ...

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up